Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency

Clinical trial NCT00018018 · COMPLETED

Trial details

NCT number: NCT00018018
Sponsor: National Human Genome Research Institute (NHGRI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Combined Immunodeficiency Syndrome

Start date: 2001-06-20
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.